Xtl Biopharmaceuticals (XTLB) Cash & Equivalents (QoQ) (2009 - 2024)
Xtl Biopharmaceuticals (XTLB) Cash & Equivalents (QoQ) (2009 - 2024) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,042.03 Bn | 67,041.74 Bn | - |
| 2 | Nanobiotix | 1,908.00 Bn | 1,907.94 Bn | - |
| 3 | Akari Therapeutics | 959.56 Bn | 959.56 Bn | - |
| 4 | BeOne Medicines | 472.89 Bn | 468.10 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 122.12 Bn | 114.87 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 70.04 Bn | 61.29 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.68 Bn | 62.68 Bn | - |
| 8 | Argenx Se | 55.90 Bn | 50.72 Bn | 1.41 Bn |
| 9 | Alnylam Pharmaceuticals | 37.47 Bn | 34.46 Bn | 959.66 Mn |
| 10 | Xtl Biopharmaceuticals | 2.58 Bn | 2.58 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | -54.76% |
| Sep 30, 2024 | 38.05% |
| Jun 30, 2024 | -44.38% |
| Mar 31, 2024 | -23.77% |
| Dec 31, 2023 | -3.84% |
| Sep 30, 2023 | -8.31% |
| Jun 30, 2023 | -16.54% |
| Mar 31, 2023 | -9.07% |
| Dec 31, 2022 | -5.93% |
| Sep 30, 2022 | -5.12% |
| Jun 30, 2022 | -15.97% |
| Mar 31, 2022 | -5.96% |
| Dec 31, 2021 | -1.39% |
| Sep 30, 2021 | 3.19% |
| Jun 30, 2021 | -14.02% |
| Mar 31, 2021 | -6.53% |
| Dec 31, 2020 | -3.22% |
| Sep 30, 2020 | -6.83% |
| Jun 30, 2020 | -5.40% |
| Mar 31, 2020 | -4.44% |